Acute encephalopathy with vigabatrin.
Sälke-Kellermann
A
A
Baier
H
H
Rambeck
B
B
Boenigk
H E
HE
Wolf
P
P
D000612:4-Aminobutyrate Transaminase / Q000009:adverse effects* / Q000037:antagonists & inhibitors*; D000293:Adolescent; D000328:Adult; D000614:Aminocaproates / Q000009:adverse effects*; D000927:Anticonvulsants / Q000009:adverse effects*; D002220:Carbamazepine / Q000009:adverse effects; D003128:Coma / Q000139:chemically induced*; D004569:Electroencephalography / Q000187:drug effects; D004828:Epilepsies, Partial / Q000188:drug therapy; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy; D005260:Female; D006801:Humans; D012640:Seizures / Q000139:chemically induced*; D020888:Vigabatrin
D000614:Aminocaproates; D000927:Anticonvulsants; D002220:Carbamazepine; D000612:4-Aminobutyrate Transaminase; D020888:Vigabatrin